This retrospective study was conducted in a specialized hospital for bariatric surgery. It included all the obese individuals who underwent an IGB insertion between January 2016 and June 2019. Patients with the following characteristics were included: aged ≥18 years, with a BMI of more than 25 kg/m2 and eligible for intragastric balloon insertion [16 (link)], who had failed supervised weight reduction programs (including diet and exercise).
Exclusion criteria included patients younger than 18 years, patients with hiatal hernia, patients with previous gastric surgery, and patients who were not followed up for at least 6 months after removal of the IGB. Patients who were receiving GLP1-antagonists were excluded from our study too.
The hospital records of the patients fulfilling the inclusion criteria were retrieved and the following data were recorded: demographic data, initial BMI, smoking status, co-morbidities, parity [nullipara, para for 1–4 parities and grandpara for more than 4 parities] [17 (link)], results of pre-IGB insertion laboratory investigations, complications encountered during the period from insertion to IGB removal, adherence to diet and exercise programs, percentage of excess weight reduction, and BMI at the time of IGB removal.
Free full text: Click here